CareLit · DOI-Nachweis · Pneumologie
Inhaled Corticosteroid Plus Long-Acting Beta2-Agonist Therapy Is Overused In The Treatment Of Patients With Chronic Obstructive Pulmonary Disease: Post Hoc Analyses Of Two 1-Year Studies
DOI 10.1055/s-0036-1572053
Bibliografische Angaben
Nachweis in CareLit
Autor:innenH Watz, GT Ferguson, L Grönke, F Voss, R Abrahams, R Buhl
ZeitschriftPneumologie
Ausgabe02/2016
Jahrgang / SeitenNicht angegeben
Kernaussage aus der Literatur
Abstract-Vorschau
Rationale: Inhaled corticosteroid (ICS) plus long-acting β2-agonist (LABA) therapy is indicated for different patient groups with chronic obstructive pulmonary disease (COPD) in the US and Europe. In the previous version of the Global initiative for chronic Obstructive Lung Disease (GOLD) recommendations, the use of ICS plus LABA therapy was restricted to patients with severe and very severe lung-function impairment…
Zitieren
Zitierempfehlung
H Watz, GT Ferguson, L Grönke, F Voss, R Abrahams, R Buhl (2016) Inhaled Corticosteroid Plus Long-Acting Beta2-Agonist Therapy Is Overused In The Treatment Of Patients With Chronic Obstructive Pulmonary Disease: Post Hoc Analyses Of Two 1-Year Studies. Pneumologie (02). https://doi.org/10.1055/s-0036-1572053
Mit CareLit weiterarbeiten